Search for: "LUPIN PHARMACEUTICALS, INC."
Results 41 - 60
of 120
Sort by Relevance
|
Sort by Date
30 Jul 2012, 9:55 pm
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
23 May 2012, 9:22 pm
Searle, LLC • Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
22 Feb 2012, 5:49 pm
Lupin, Ltd. et al. [read post]
7 Sep 2011, 4:22 am
Apotex (Patently-O) Glivec (Imatinib mesylate) – India: The Glivec patent saga – its raining recusals (Spicy IP) Glivec (Imatinib mesylate) – India: Supreme Court to hear Novartis challenge to India’s patent law (IP Watch) Lo Loestrin Fe (Norethindrone acetate / Ethinyl estradiol / Ferrous fumarate) – US: Warner Chilcott files patent infringement complaint against Lupin in response to Para IV certification (Patent Docs) Lumigan (Bimatoprost) – US:… [read post]
10 Aug 2011, 4:30 am
Lupin Ltd. et al. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Holman’s Biotech IP Blog) US: Myriad writes to CAFC on standing issue (Patent Docs) (Patent Docs) (Holman’s Biotech IP Blog) US: In the first 7 months of 2011, the FDA has approved 18 new molecular entity pharmaceutical drugs (and no biologic NMEs) (KEI) US: Embryonic stem cell funding suit dead: Sherley v. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
29 Jun 2011, 3:34 am
Sagent Pharmaceuticals, Inc. et al. [read post]
15 Jun 2011, 4:56 am
Par Pharmaceutical, Inc. [read post]
1 Jun 2011, 5:51 pm
Karst – Last week, in a seven-page response, FDA denied an October 18, 2010 Citizen Petition submitted on behalf of Lupin Limited (“Lupin”) requesting that FDA determine that Teva Pharmaceuticals USA, Inc. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
3 Apr 2011, 9:44 pm
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
7 Feb 2011, 6:53 pm
In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
20 Jan 2011, 1:03 pm
Patent No. 7,101,574 ("the ‘574 patent") covering ANTARA (fenofibrate) Capsules, which is approved under NDA No. 21-695, and granted a Motion to Dismiss filed by defendants Ethypharm S.A., Lupin Limited, and Lupin Pharmaceuticals, Inc. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
10 Nov 2010, 6:22 am
Lupin Pharms., Inc., 603 F.3d 1377 (Fed. [read post]